World AIDS Day 2021
December 1st is World AIDS Day, and CDC invites you to join in its observance. This year the U.S. Government’s theme, “Ending the HIV Epidemic: Equitable Access, Everyone’s Voice,” highlights our commitment to ending the HIV epidemic globally. It also highlights the importance of ensuring equitable access to quality, people-centered HIV prevention and treatment services and that the voices of all who are living with or affected by HIV are heard and valued in the AIDS response.
With support from the U.S. President’s Emergency Plan for AIDS Relief (PEPFAR)external icon, CDC works with ministries of health; private, civil society, and faith-based organizations; and other on-the-ground partners to improve methods for finding, treating, and preventing HIV infections. CDC is helping drive progress toward HIV epidemic control using testing, treatment, and prevention services focused on populations that are disproportionately impacted by HIV.
Statement from CDC leaders on progress toward HIV epidemic control.
In the face of remarkable progress, we have also faced unprecedented challenges, as the COVID-19 pandemic threatened to stymie progress and reverse hard-fought gains. However, CDC’s longstanding investments through PEPFAR – in laboratory science, in surveillance and health information systems, building healthcare workforce and community capacity – better prepared us to respond to COVID-19 in the countries where we work and enabled us to avoid the worst-case scenarios projected in early 2020.
Highlight of CDC’s contributions to HIV testing, treatment, and prevention achievements as part of PEPFAR.
Voluntary Medical Male Circumcisions
PEPFAR: 25.3 Million
CDC: 13 Million
People Who Received a
Positive HIV Test Result**
PEPFAR: 2.7 Million
CDC: 1.6 Million
HIV-Positive Persons Screened in Care for TB***
PEPFAR: 13.6 Million
CDC: 8.1 Million
Antiretroviral Treatment to
Prevent Mother-to-child Transmission***
*Other USG agencies may have also contributed to some of these achievements **As of Sept 30, 2020 ***FY2020 ****Cumulative through Sept 30, 2020
Learn how CDC and partners adapted services to sustain and expand key HIV treatment and prevention activities during the COVID-19 pandemic.
Amplifying U=U Message Through Social Media
Timely diagnosis of HIV infection and sustained antiretroviral treatment (ART) increases the quality of life for a person living with HIV and prevents the spread of the virus.
Enhancing Access to Safe and Equitable HIV Services for Key Populations in Lagos
Members of key populations are most vulnerable to acquiring HIV and bear a disproportionate burden of HIV compared to the general population.
Empowering Adolescents and Young People living with HIV in Ethiopia
In 2020, about 1.75 million children and adolescents between the ages of 10 and 19 were living with HIV (C/ALHIV) worldwide (UNAIDS 2021).
Innovations to Sustain Critical HIV Services during the COVID-19 Pandemic
Measures enacted to mitigate the spread of COVID-19 posed challenges for HIV testing, treatment, and prevention services in PEPFAR-supported countries, including South Africa, where 19.1 percent of adults aged 15-49 are HIV-positive (2020). To sustain critical HIV services during the pandemic, CDC implementing partners adapted services, such as multi-month dispensing of antiretroviral treatment (ART), HIV self-testing, community-based interventions, and differentiated delivery models to minimize disruptions in the delivery of services for people living with HIV and limiting exposure to COVID-19.
Partnering to End the HIV Epidemic Worldwide
Lieutenant Commander Minesh Shah, MD, MPH of CDC Ethiopia, an internal medicine physician and a medical officer, and Dr. Jonathan Hanft of the Hennepin County Health Department discuss insights from the global and domestic HIV response efforts.
Latest research from CDC on global HIV and TB.
- Forced Sexual Initiation and Early Sexual Debut and Associated Risk Factors and Health Problems Among Adolescent Girls and Young Women — Violence Against Children and Youth Surveys, Nine PEPFAR Countries, 2007–2018. Adolescent girls and young women aged 13 – 24 years, are disproportionately affected by HIV in sub-Saharan Africa resulting from biological, behavioral, and structural factors, including violence. Prevention of sexual violence and early sexual debut are vital components of CDC and PEPFAR-supported programs to control the HIV epidemic. Read more
- Derivation and External Validation of a Risk Score for Predicting HIV-Associated Tuberculosis to Support Case Finding and Preventive Therapy Scale-Up: A Cohort Study. Among people living with HIV, more flexible and sensitive tuberculosis (TB) screening tools capable of detecting both symptomatic and subclinical active TB are needed to (1) reduce morbidity and mortality from undiagnosed TB; (2) facilitate scale-up of tuberculosis preventive therapy. Read moreexternal icon
- Tuberculosis Treatment within Differentiated Service Delivery Models in Global HIV/TB Programming. Providing more convenient and patient-centered options for service delivery is a priority within global HIV programs. These efforts improve patient satisfaction and retention and free up time for providers to focus on new HIV diagnoses or severe illness. Read moreexternal icon
- Risk Scores for Predicting Early Antiretroviral Therapy Mortality in sub-Saharan Africa to Inform Who Needs Intensification of Care: A Derivation and External Validation Cohort Study. Clinical scores to determine early antiretroviral therapy (ART) mortality risk have not been developed for sub-Saharan Africa, home to 70% of people living with HIV. In the absence of validated scores, WHO eligibility criteria for ART care intensification are CD4 . Read moreexternal icon
Visit the PEPFAR website to learn how PEPFAR and CDC are leading efforts to control the HIV epidemic worldwide.
An overview of CDC’s global efforts and return on investments in responding to one of the world’s greatest health threats.
Since its inception, CDC has played a critical role in PEPFAR’s efforts to save millions of lives across the globe.